NCT04905732

Brief Summary

Invasive ventilation(IV) remains one key cornerstone to reduce neonatal mortality for preterm infants with respiratory distress syndrome(RDS) and/or acute respiratory distress syndrome(ARDS). However, it is also related to increased risks of ventilator-associated lung injury and escalation of pulmonary inflammation, and which finally result in bronchopulmonary dysplasia (BPD). Early weaning from IV in newborn infants with BPD is therefore a key procedure to reduce these risks above.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

May 20, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 28, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

3.6 years

First QC Date

February 26, 2021

Last Update Submit

October 13, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • re-intubation rate

    the newborn infants with ventilated BPD is reintubated after extubation

    seven days after extubation

  • death

    the newborn infants with BPD die

    seven days after extubation

  • the level of carbon dioxide

    the level of carbon dioxide is measure after extubation between groups

    seven days after extubation

Secondary Outcomes (2)

  • necrotizing entercolitis(NEC)

    seven days after extubation

  • intraventricular hemorrhage(IVH)

    seven days after extubation

Study Arms (2)

NHFOV

EXPERIMENTAL

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NHFOV

Device: NHFOV

NCPAP

ACTIVE COMPARATOR

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NCPAP

Device: NCPAP

Interventions

NHFOVDEVICE

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NHFOV

NHFOV
NCPAPDEVICE

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NCPAP

NCPAP

Eligibility Criteria

Age28 Days - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Eligibility requirements for neonates:
  • The gestational age is less than 32 weeks
  • The preterm neonates are diagnosed with BPD and need invasive ventilation
  • Extubation and subsequent noninvasive ventilation is ready to be carried out

You may not qualify if:

  • one of the following conditions is needed:
  • there were no intraventricular hemorrhage(IVH) grades 3 or 4
  • major congenital anomalies
  • parents' decision not to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chen(陈)

Chongqing, Chongqing Municipality, 400014, China

RECRUITING

MeSH Terms

Conditions

Bronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Chen(陈) Long, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
After documenting parental consent, these ventilated infants with BPD were randomly assigned to either NHFOV or NCPAP using a table of random numbers and sealed opaque envelopes when they were eligible for extubation. Blinding to doctor was not possible due to the nature of the intervention, is not necessary to participant.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: After documenting parental consent, the ventilated infants with BPD were randomly assigned to either NHFOV or NCPAP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

February 26, 2021

First Posted

May 28, 2021

Study Start

May 20, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

October 14, 2022

Record last verified: 2022-10

Locations